iC3 Summit 2019
 

Sponsor / Exhibit

Sponsor & Exhibitor Opportunities Still available
 

September 26th& 27th2019 – Dallas-Fort Worth

About the iC3TM Life Science Summit

Launched in 2014, the iC3TM Life Science Summit serves as a forum for leaders to discuss strategic issues, exhibit the broad spectrum of North Texas life science products and services, and to network with each other so as to grow business through collaborative efforts. Attendees range from the startup community through large multinationals representing industry sectors such as biotech, pharma, healthcare companies, academic research institutions, innovators, and leaders.

– VIP Dinner Reception –

September 26th2019
6:00 pm – 9:00 pm

American Airlines
CR Smith Museum
4601 Highway 360
Fort Worth, TX 76155

– Conference & Exhibits –

September 27th2019
7:30 am – 4:30 pm

E.H. Hereford University Center
University of Texas at Arlington
300 W First Street
Arlington, TX 76010

 

Latest News

2019 Dennis K. Stone Award recipient announced!

Successful entrepreneur & investor Paul Dorman named bionorthTX™ 2019 Dennis K. Stone Award Recipient…
 
 

iC3™ Life Sciences Summit Conference Agenda – September 27 2019

7:30 – 8:30                 Breakfast Event: Women in Science Trailblazers

  • Successful women detail their journey and speak to the importance of mentorship in professional advancement for the next generation of women. This event is hosted by the WIS Committee and is open to all iC3 Attendees who want to be inspired by the stories of these trailblazers and how they implement mentorship to drive professional advancement.

8:30 – 8:45                 Breakfast, Exhibits & Networking

8:45 – 9:00                 Welcome Address – Bio North Texas Chairman

9:00 – 9:30                 BioTech and Healthcare Developments in Texas

  • Texas Healthcare and Bioscience Institute CEO Tom Kowalski provides an update on the state of the industry in Texas, the latest updates from the legislative sessions, and the importance of organizations like CPRIT to the industry.

9:30 – 9:45                 Rising Stars Spotlight – OncoNano Medicine

  • OncoNano is the first company to advance product candidates using pH as a biomarker for cancer immunotherapy, therapeutic use and intra-operative imaging based on its pH-sensitive micelle technology. pH is an indicator for several diseases including cancer, Alzheimer’s and metabolic disorders. By targeting pH, a clear delineation between diseased and healthy tissue can be digitalized to develop a broad range of targeted applications.

9:45 – 10:00               Break: Exhibits & Networking

10:00 – 10:30            The BioTech Community – Resources in North Texas

  • This interactive panel will explore the existing resources in the community and answer questions on where and what is available to the community.

10:30 – 11:15            The State of the Biotech Industry – Issues and Advocacy

  • National and global perspectives from the Jim Greenwood the CEO of BIO, the organization that is the champion of the biotech industry. Areas of interest will include new opportunities and upcoming challenges in legislation, innovation, regulatory, and other areas.

11:15 – 11:30            Rising Stars Spotlight – Barricade Therapeutics

  • Despite newer therapies such as EGFR, VEGF inhibitors & immuno-oncology agents, Colorectal Cancer remains a deadly disease with ~50,000 deaths annually in the US alone. Barricades’s TASIN has shown to be highly potent, resulting in significant inhibition of CRC tumor growth, with no apparent toxicity to normal cells.

11:30 – 12:00            Buffet Hot Lunch and Exhibit and Networking

12:00 – 12:30            The ALCON Journey

  • Halden Conner shares first hand experiences as he takes us on the journey of locally founded Alcon – from the early days with founders Robert Alexander and William Conner through the latest spin-off from Novartis.

12:30 – 1:00               Dennis K. Stone Award

  • The Dennis K. Stone Award is presented annually by bionorthTX™to an individual who has positively affected quality of life by raising awareness and funds for life science research, who has impacted innovation to bring discoveries to commercial relevance, and who has given back to their community and those in the scientific field as a supporter, mentor, leader, or educator.

1:00 – 1:15                 Break: Exhibits & Networking

1:15 – 1:30                 Rising Stars Spotlight – NeuroRehab VR

  • The brain has the ability to form and reorganize synaptic connections, both functionally and physically in response to new learning or physical therapy following an injury to its brain cells. Neuroplasticity of the brain is the underlying concept behind the science of NeuroRehab VR therapeutic virtual reality “games”.

1:30 – 2:15                 Biologistics: Advancing Supply Chains, Logistics, and Transportation of Bio-Products   

  • Biologistics has been defined as the management of the safe flow of high value, temperature sensitive, and time-critical biological materials as they are delivered for patient care, analyzed for diagnostic purposes, processed to higher value products or stored to meet physical and data archival needs. What are the challenges faced by this rapidly developing industry sector? What impact will CEIV certification of DFW Airport partner companies have on the region? How can North Texas companies capitalize on the CEIV certification?

2:15 – 2:30                 Rising Stars Spotlight – CerSci Therapeutics

  • For too long the options for patients reliant on opioids and those in chronic pain have been too limited. CerSci Therapeutics is poised to deliver a new generation of non-opioid medicines to treat acute post-operative and chronic neuropathic pain.

2:30 – 3:15                 Angel Investors, Family Offices, Venture Capital, and Private Equity: How They Play the Game

  • North Texas life sciences startups seem to have garnered the attention of early stage investors nationally but continue to struggle in capital raises in later rounds, especially from local investors. Panelists will address such issues as how raising capital from these sources differ, what they want for their money, how they collaborate, and how the process differs.

3:15 – 3:30                 Closing Remarks

  • Dr. Vistasp Kharbari shares with us the importance of Innovation, Collaboration, Capital, and Commercialization in developing a robust biotech and healthcare community

3:30 – 4:00                 Exhibits & Networking